Does the 13-valent pneumococcal vaccine require dietary restrictions?

Apr 03, 2023 Source: Cainiu Health

Dr. Guo Xiheng

Introduction

It is not necessarily required to avoid certain foods after receiving the 13-valent pneumococcal vaccine; this should be determined based on the baby's individual health condition. After vaccination, it is important to closely monitor the baby's mental state. If any discomfort or adverse symptoms occur, seek medical attention promptly to avoid delaying treatment and causing harm to the baby's health. During recovery, ensure the baby gets plenty of rest.

The 13-valent pneumococcal vaccine does not necessarily require dietary restrictions; this should be determined based on the baby's individual health condition.

1. Dietary restrictions needed

If the baby is in poor health or has an allergic constitution, there may be an allergic reaction to foreign proteins. After receiving the 13-valent pneumococcal vaccine, the mother should avoid certain foods containing heterologous animal proteins, such as eggs, shrimp, and fish, to prevent possible vaccine-related allergic reactions in the baby. Generally, after 3–6 days following vaccination, the immune response will have been established, after which the mother no longer needs to maintain dietary restrictions.

2. No dietary restrictions needed

If the baby is in good health and does not have an allergic constitution, the mother usually does not need to follow any special dietary restrictions after the baby receives the 13-valent pneumococcal vaccine and can maintain a normal diet.

After receiving the 13-valent pneumococcal vaccine, it is important to closely monitor the baby’s mental state and overall well-being. If any adverse symptoms occur, prompt medical attention should be sought to avoid delaying treatment and causing harm to the baby’s health.

View All

Does the 13-valent pneumococcal vaccine cause fever with every dose?

Fever generally refers to an elevated body temperature. Not everyone will experience fever after receiving each dose of the 13-valent pneumococcal vaccine; however, some individuals may develop a fever, which is considered a common adverse reaction. If the fever is low-grade, no special treatment is required. It is recommended to drink more hot water at home, and symptoms usually resolve spontaneously after 2–3 days of rest. If a high fever develops, exceeding 38.5°C, antipyretic treatment should be administered.

View Full Answer

What causes fever after receiving the final dose of the 13-valent pneumococcal vaccine?

Fever generally refers to an elevated body temperature. Fever after receiving the final dose of the 13-valent pneumococcal vaccine may be due to adverse reactions from the vaccine or caused by a viral infection. During the process in which the vaccine stimulates the body to produce antibodies, fever may occur as a normal vaccine reaction. Typically, the fever is mild and lasts for about 1 to 3 days before resolving on its own.

View Full Answer

What causes fever after receiving the fourth dose of the 13-valent pneumococcal vaccine?

Fever generally refers to an elevated body temperature. Fever after receiving the fourth dose of the 13-valent pneumococcal vaccine may be due to an adverse reaction to the vaccine or a viral infection such as the common cold. Therefore, symptoms such as fever, rash, diarrhea, and increased sleep may occur after administration of the 13-valent vaccine. If symptoms are not severe, it is recommended to drink plenty of fluids, get adequate rest, and avoid fatigue and staying up late. Adverse reactions usually resolve on their own.

View Full Answer

What is the difference between the 13-valent pneumococcal vaccine and the 23-valent pneumococcal vaccine?

The differences between the 13-valent pneumococcal vaccine and the 23-valent pneumococcal vaccine include variations in vaccination coverage, technology, target populations, and more. The 13-valent pneumococcal vaccine protects against 13 types of Streptococcus pneumoniae, while the 23-valent pneumococcal vaccine protects against 23 types, offering broader coverage than the 13-valent vaccine. In addition to these differences, the two vaccines also differ in their compositional components.